skip to main content
UK Health Security Agency

Human adenovirus 23

Human adenovirus 23

Catalogue No.

17081001v

Virus Name

Human adenovirus 23

ICTV Species Name

Human mastadenovirus D

Strain Info

Depositor

Public Health England

Originally Isolated

In Hep-2 cells from faeces of an HIV-positive 63 year-old patient positive for Candida in the oropharynx in 1993 by Andrew Bailey of the Manchester Central Laboratory Services. Passaged twice in Hep-2 cells prior to depositing into NCPV.

Serotype/Subtype

Serotype 23

Original Reference

Alkhalaf MA et al (2014)

Sequence Reference

KF279629.1

Culture Conditions

Mycoplasma Status

Positive

Storage Conditions

Store at or below -70°C

Host Cell Types

Cell lines this virus has been successfully cultured at NCPV: Hep-2, ECACC cat no. 86030501; A549, ECACC cat no. 86012804

Additional Info

SAPO Restrictions

1

Hazard Group (ACDP)

2

Genetically Modified

No

Available Formats

  • Ampoule (Virus)

If the use of our viruses results in a scientific publication, it should be cited in the publication as: Human adenovirus 23 (NCPV 17081001v).

It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.